The FDA has said it will seek the advice of independent advisors before it concludes its review of Eli Lilly ... % fall after hours. Lilly’s head of neuroscience, Anne White, said the ...

Eli Lilly has been unable to secure an accelerated ... Lilly's head of neuroscience R&D Anne White said the company is confident that TRAILBLAZER-ALZ 2 will back up the results of its phase ...

(Reuters) - Eli Lilly (LLY) is betting big on its experimental oral weight-loss drug even before reporting data from its late-stage trial by recording nearly $550 million in "pre-launch inventory ...

Feb. 26 (UPI) --Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the United States and make the nation the world's leader in ...